Research Article
Overexpression of ICAM-1 Predicts Poor Survival in High-Grade Serous Ovarian Carcinoma: A Study Based on TCGA and GEO Databases and Tissue Microarray
Table 1
Association between ICAM-1 expression and clinicopathological parameters in patients with high-grade serous ovarian carcinoma.
| Characteristics | n = 103 | ICAM-1 Expression | X2 | P | Over-expression (%) | Low expression (%) |
| Age | | | | | | ≤50 | 42 | 22 (52.4) | 20 (47.6) | | | >50 | 61 | 43 (70.5) | 18 (29.5) | 3.504 | 0.061 | Stage | | | | | | Early (I-II) | 31 | 15 (48.4) | 16 (51.6) | | | Advanced (III-IV) | 40 | 29 (72.5) | 11 (27.5) | 4.309 | 0.038 | unknown | 32 | | | | | Ascites | | | | | | No | 16 | 9 (56.2) | 7 (43.8) | | | Yes | 44 | 29 (65.9) | 15 (34.1) | 0.471 | 0.492 | unknown | 43 | | | | | Chemotherapy resistance | | | | | | No | 36 | 21 (58.3) | 15 (41.7) | | | Yes | 20 | 17 (85.0) | 3 (15.0) | 4.192 | 0.041 | unknown | 47 | | | | |
|
|